10. Musculoskeletal & joint diseases

All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.

Back

Chapters Toggle Chapters

Chapter 1: Gastrointestinal Chapter 2: Cardiovascular Chapter 3: Respiratory Chapter 4: Central Nervous System Chapter 5: Infections Chapter 6: Endocrine Chapter 7: Obstetrics, gynaecology, and urinary-tract disorders Chapter 8: Immunomodulatory treatments and malignant disease Chapter 9: Blood and nutrition Chapter 10: Musculoskeletal & joint diseases Chapter 11: Eye Chapter 12: Ear, nose & oropharynx Chapter 13: Skin Chapter 14: Immunological products and vaccines Chapter 15: Anaesthesia Chapter 16: Palliative Care Chapter 17: Wound Management Formulary Chapter 18: Continence

Chapter 10: Musculoskeletal & joint diseases

Prescribing non-steroidal anti-inflammatory drugs (NSAIDs) Management of gout Management of rheumatoid arthritis 10.1 Drugs used in rheumatic diseases and gout 10.2 Drugs used in neuromuscular disorders 10.3 Drugs for the treatment of soft-tissue disorders and topical pain relief

Referral Guidelines - Musculoskeletal and Joint Disorders (Eastern Locality)

Referral Guidelines - Musculoskeletal and Joint Disorders (Northern Locality)

NICE TA477: Autologous chondrocyte implantation for treating symptomatic articular cartilage defects of the knee (October 2017)

NICE TA508: Autologous chondrocyte implantation using chondrosphere for treating symptomatic articular cartilage defects of the knee (March 2018)

NICE TA304 Total hip replacement and resurfacing arthroplasty for end-stage arthritis of the hip (February 2014)